Scilex Holding (SCLX) Profit After Tax (QoQ) (2020 - 2026)

Scilex Holding (SCLX) Profit After Tax (QoQ) (2020 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,162,528.78 Bn 93,162,523.82 Bn 7.76 Bn
2 Eli Lilly 1,017.87 Bn 1,012.58 Bn 16.22 Bn
3 Johnson & Johnson 575.51 Bn 553.46 Bn 15.96 Bn
4 AbbVie 400.43 Bn 391.08 Bn 10.78 Bn
5 Merck 294.19 Bn 288.54 Bn 12.09 Bn
6 Amgen 182.41 Bn 170.37 Bn 5.87 Bn
7 Gilead Sciences 150.97 Bn 143.24 Bn 5.52 Bn
8 Pfizer 145.75 Bn 132.97 Bn -1.21 Bn
9 Bristol Myers Squibb 113.35 Bn 102.90 Bn 8.07 Bn
10 Scilex Holding 57.99 Mn -91.94 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 0.99%
Dec 31, 2025 82.12%
Sep 30, 2025 -485.32%
Jun 30, 2025 -68.90%
Mar 31, 2025 -303.72%
Dec 31, 2024 -47.22%
Sep 30, 2024 88.32%
Jun 30, 2024 -54.17%
Mar 31, 2024 -13.91%
Dec 31, 2023 39.77%
Sep 30, 2023 -33.32%
Jun 30, 2023 13.35%
Mar 31, 2023 -71.96%
Dec 31, 2022 -183.18%
Sep 30, 2022 220.53%
Jun 30, 2022 -95.10%
Mar 31, 2022 89.62%
Dec 31, 2021 -5,997.87%
Sep 30, 2021 -517.91%
Jun 30, 2021 -117.59%